Terug
Dagbereik
€ 29,28
€ 30,42
52-Weeksbereik
€ 12,47
€ 37,35
Volume
8.167.584
50D / 200D Gem.
€ 32,63
/
€ 23,84
Vorige Slotkoers
€ 29,14
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 24,3 | 0,2 |
| P/B | 4,3 | 3,0 |
| ROE % | 21,2 | 3,5 |
| Net Margin % | 8,2 | 3,8 |
| Rev Growth 5Y % | 2,1 | 9,7 |
| D/E | 2,2 | 0,2 |
Koersdoel Analisten
Hold
€ 38,33
+30.1%
Low: € 35,00
High: € 41,00
Forward K/W
10,89
Forward WPA
€ 2,70
WPA Groei (sch.)
+0,0%
Omzet Sch.
16,66B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,06
€ 4,01 – € 4,12
|
19,10B | 1 |
| FY2029 |
€ 3,58
€ 3,54 – € 3,64
|
18,25B | 1 |
| FY2028 |
€ 3,44
€ 2,25 – € 4,45
|
17,90B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-28 | € 0,64 | € 0,96 | +49,8% |
| 2025-11-05 | € 0,68 | € 0,78 | +14,7% |
| 2025-07-30 | € 0,63 | € 0,66 | +4,8% |
| 2025-05-07 | € 0,47 | € 0,52 | +10,6% |
| 2025-01-29 | € 0,69 | € 0,71 | +2,9% |
| 2024-11-06 | € 0,65 | € 0,69 | +6,2% |
| 2024-07-31 | € 0,57 | € 0,61 | +7,0% |
| 2024-05-08 | € 0,51 | € 0,48 | -5,9% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Nov 27, 2017 | Dec 12, 2017 | € 0,09 | 5,80% |
| Aug 25, 2017 | Sep 14, 2017 | € 0,09 | 6,82% |
| Jun 01, 2017 | Jun 22, 2017 | € 0,34 | 4,69% |
| Feb 28, 2017 | Mar 20, 2017 | € 0,34 | 3,88% |
| Dec 01, 2016 | Dec 20, 2016 | € 0,34 | 3,72% |
| Aug 18, 2016 | Sep 08, 2016 | € 0,34 | 2,56% |
| May 20, 2016 | Jun 07, 2016 | € 0,34 | 2,62% |
| Feb 25, 2016 | Mar 14, 2016 | € 0,34 | 2,36% |
| Nov 13, 2015 | Dec 03, 2015 | € 0,34 | 2,34% |
| Aug 18, 2015 | Sep 03, 2015 | € 0,34 | 1,94% |
| May 15, 2015 | Jun 04, 2015 | € 0,34 | 2,25% |
| Feb 17, 2015 | Mar 03, 2015 | € 0,34 | 2,39% |
| Nov 13, 2014 | Dec 02, 2014 | € 0,32 | 2,39% |
| Aug 19, 2014 | Sep 04, 2014 | € 0,35 | 2,60% |
| May 16, 2014 | Jun 02, 2014 | € 0,35 | 2,69% |
| Feb 20, 2014 | Mar 10, 2014 | € 0,35 | 2,72% |
| Nov 18, 2013 | Dec 03, 2013 | € 0,33 | 3,35% |
| Aug 16, 2013 | Sep 03, 2013 | € 0,32 | 3,02% |
| May 16, 2013 | Jun 03, 2013 | € 0,32 | 2,84% |
| Feb 19, 2013 | Mar 07, 2013 | € 0,31 | 2,81% |
Belangrijkste Punten
Revenue grew 2,10% annually over 5 years — modest growth
ROE of 21,23% indicates high profitability
Debt/Equity of 2,20 — high leverage
Generating 1,15B in free cash flow
Cash machine — converts 81,42% of earnings into free cash flow
Capital efficient — spends only 2,90% of revenue on capex
Groei
Revenue Growth (5Y)
2,10%
Revenue (1Y)4,31%
Earnings (1Y)N/A
FCF Growth (3Y)16,77%
Kwaliteit
Return on Equity
21,23%
ROIC6,40%
Net Margin8,17%
Op. Margin12,50%
Veiligheid
Debt / Equity
2,20
Current Ratio1,04
Interest Coverage2,35
Waardering
P/E Ratio
24,33
Forward P/E10,89
P/B Ratio4,34
EV/EBITDA22,32
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,31% | Revenue Growth (3Y) | 4,36% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,10% | Earnings Growth (5Y) | 35,60% |
| Profitability | |||
| Revenue (TTM) | 17,26B | Net Income (TTM) | 1,41B |
| ROE | 21,23% | ROA | 3,46% |
| Gross Margin | 51,79% | Operating Margin | 12,50% |
| Net Margin | 8,17% | Free Cash Flow (TTM) | 1,15B |
| ROIC | 6,40% | FCF Growth (3Y) | 16,77% |
| Safety | |||
| Debt / Equity | 2,20 | Current Ratio | 1,04 |
| Interest Coverage | 2,35 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 24,33 | Forward P/E | 10,89 |
| P/B Ratio | 4,34 | P/S Ratio | 1,99 |
| PEG Ratio | -0,14 | Forward PEG | N/A |
| EV/EBITDA | 22,32 | Fwd EV/EBITDA | 18,91 |
| Forward P/S | 2,06 | Fwd Earnings Yield | 9,18% |
| FCF Yield | 3,35% | ||
| Market Cap | 34,31B | Enterprise Value | 48,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17,26B | 16,54B | 15,85B | 14,93B | 15,88B |
| Net Income | 1,41B | -1,64B | -559,00M | -2,45B | 417,00M |
| EPS (Diluted) | 1,20 | -1,45 | -0,50 | -2,20 | 0,38 |
| Gross Profit | 8,94B | 8,06B | 7,65B | 6,97B | 7,59B |
| Operating Income | 2,16B | -303,00M | 433,00M | -2,20B | 1,72B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40,75B | 39,33B | 43,48B | 44,01B | 47,67B |
| Total Liabilities | 32,83B | 33,61B | 35,35B | 35,41B | 36,42B |
| Shareholders' Equity | 7,91B | 5,37B | 7,51B | 7,80B | 10,28B |
| Total Debt | 17,38B | 18,08B | 20,15B | 21,56B | 23,46B |
| Cash & Equivalents | 3,56B | 3,30B | 3,23B | 2,80B | 2,17B |
| Current Assets | 13,95B | 12,55B | 12,49B | 12,05B | 12,57B |
| Current Liabilities | 13,46B | 12,80B | 12,25B | 11,47B | 11,03B |